Literature DB >> 6406469

Metabolism and kinetics of bupropion.

D H Schroeder.   

Abstract

Studies of bupropion in rats, dogs, and normal volunteers showed that bupropion was rapidly and completely absorbed, widely distributed in tissues, and metabolized extensively prior to its excretion. Metabolism in rats and dogs appeared to be predominantly by side chain oxidative cleavage, while reduction of the intact parent aminoketone to an aminoalcohol was an additional major pathway in man. Most of the metabolites were excreted in urine. Bupropion, but not its metabolites, was concentrated in many tissues, with a brain to plasma ratio of about 25:1. Plasma protein binding of bupropion (75%-80%) did not seem to limit its tissue distribution. Bupropion was found to be a weak to moderate inducer of drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406469

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  29 in total

Review 1.  Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine.

Authors:  S Rotzinger; M Bourin; Y Akimoto; R T Coutts; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 2.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

3.  The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs.

Authors:  C L DeVane; S C Laizure; D F Cameron
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  A case report of seizure induced by bupropion nasal insufflation.

Authors:  Stanley Hill; Harminder Sikand; Jonathan Lee
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

5.  Metabolism of bupropion by carbonyl reductases in liver and intestine.

Authors:  Jamie N Connarn; Xinyuan Zhang; Andrew Babiskin; Duxin Sun
Journal:  Drug Metab Dispos       Date:  2015-04-22       Impact factor: 3.922

6.  Evaluation of a Potential Clinical Significant Drug-Drug Interaction between Digoxin and Bupropion in Cynomolgus Monkeys.

Authors:  Yang Shen; Yang Yu; Wei Lai; Shuai Li; Zixuan Xu; Jiejing Jin; Xia Yan; Han Xing; Xijing Chen; Aizhen Xiong; Chunhua Xia; Jiake He; Kui Hong
Journal:  Pharm Res       Date:  2018-11-06       Impact factor: 4.200

7.  Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.

Authors:  Arne Meyer; Anna Vuorinen; Agnieszka E Zielinska; Petra Strajhar; Gareth G Lavery; Daniela Schuster; Alex Odermatt
Journal:  Drug Metab Dispos       Date:  2013-06-26       Impact factor: 3.922

8.  Identification and Structural Characterization of Three New Metabolites of Bupropion in Humans.

Authors:  Jennifer E Sager; John R Choiniere; Justine Chang; Alyssa Stephenson-Famy; Wendel L Nelson; Nina Isoherranen
Journal:  ACS Med Chem Lett       Date:  2016-06-17       Impact factor: 4.345

9.  Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study.

Authors:  Alice Egerton; John P Shotbolt; Paul R A Stokes; Ella Hirani; Rabia Ahmad; Julia M Lappin; Suzanne J Reeves; Mitul A Mehta; Oliver D Howes; Paul M Grasby
Journal:  Neuroimage       Date:  2009-12-05       Impact factor: 6.556

10.  Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus).

Authors:  Erik Rytting; Xiaoming Wang; Daria I Vernikovskaya; Ying Zhan; Cassondra Bauer; Susan M Abdel-Rahman; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Drug Metab Dispos       Date:  2014-08-05       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.